COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care Post published:January 8, 2021 Post category:Press Release
Mount Sinai Health System Launches Center for Psychedelic Research Post published:January 7, 2021 Post category:Press Release
BetterLife Announces Formation of Next Generation Psychedelic Research Advisory Board Post published:January 7, 2021 Post category:Press Release
Ehave, Inc. Partners with Cognitive Apps to Add Artificial Intelligence-Powered Mental Health Analytical Platform for Psychedelic Use in G20 Countries Post published:January 7, 2021 Post category:Press Release
Ontario Brain Institute Increases Investment in Diamond Therapeutics to Accelerate Innovation in Mental Health Post published:January 7, 2021 Post category:Press Release
Havn Life Sciences announces closing of C$11.5 million Bought Deal Financing Post published:January 7, 2021 Post category:Press Release
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand Post published:January 7, 2021 Post category:Press Release
Red Light Holland Announces $5 Million Bought Deal Equity Financing Post published:January 7, 2021 Post category:Press Release
Mydecine Innovations Group Shares Intellectual Property Update Post published:January 7, 2021 Post category:Press Release
Field Trip Health Ltd. Announces Participation in a MAPS-sponsored Multi-Site Study of MDMA-Assisted Therapy to Treat Eating Disorders Post published:January 7, 2021 Post category:Press Release